München
08.07.25 | 09:18
0,019 Euro
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 24.06. | Polarean Imaging PLC - Promotion & sales representative agreement | - | RNS | ||
| 09.06. | Polarean Imaging PLC - Result of AGM | - | RNS | ||
| 02.06. | Polarean: FDA expands XENOVIEW indication to include children from six years of age | 1 | GlobeNewswire (USA) | ||
| 02.06. | Polarean Imaging gets go-ahead to expand Xenoview use | 1 | Sharecast | ||
| 02.06. | Polarean Imaging PLC - FDA expands XENOVIEW indication | - | RNS | ||
| 21.05. | Polarean Imaging PLC - Dr. Bastiaan Driehuys awarded by ATS | - | RNS | ||
| 15.05. | Polarean: Xenon MRI Featured Prominently at ATS 2025 Across Broad Clinical Spectrum | 1 | GlobeNewswire (USA) | ||
| POLAREAN IMAGING Aktie jetzt für 0€ handeln | |||||
| 15.05. | Polarean Imaging's Xenon-MRT gewinnt an Bedeutung in der Lungenmedizin | 2 | Investing.com Deutsch | ||
| 15.05. | Polarean Imaging's Xenon MRI gains traction in pulmonary medicine | 1 | Investing.com | ||
| 15.05. | Polarean Imaging PLC - Xenon MRI featured prominently at ATS 2025 | - | RNS | ||
| 14.05. | AIM Market Roundup: H&T, Polarean Imaging, Corcel | 2 | The Armchair Trader | ||
| 14.05. | Polarean Imaging PLC - Ongoing collaboration with Philips | 2 | RNS | ||
| 08.05. | Polarean Imaging PLC - Final Results | - | RNS | ||
| 25.04. | Polarean Imaging PLC - Notice of Results | - | RNS | ||
| 10.03. | Polarean Imaging PLC - Expansion of Xenon MRI imaging platform | 1 | RNS | ||
| 27.02. | Polarean Imaging PLC - FY24 trading update | - | RNS | ||
| 19.02. | Polarean Imaging PLC - Virtual Investor Day | - | RNS | ||
| 03.02. | Polarean Imaging shares jump as inks first distribution deal in Taiwan | - | Alliance News | ||
| 03.02. | Polarean Imaging PLC - Taiwanese distributor agreement with Sumtage | - | RNS | ||
| 30.01. | Polarean Imaging PLC - Key patent in China secured | - | RNS |
1 2 Weiter >>
22 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDTRONIC | 75,57 | +1,00 % | Medtronic Appoints Chad Spooner As CFO | WASHINGTON (dpa-AFX) - Medtronic plc (MDT), a healthcare technology, on Tuesday announced that it has appointed Chad Spooner as Chief Financial Officer of MiniMed, with effect from July 14.... ► Artikel lesen | |
| HCA HEALTHCARE | 322,00 | +0,25 % | HCA Healthcare stock rating reiterated at Overweight by Cantor Fitzgerald | ||
| LANTHEUS | 70,56 | +4,38 % | Lantheus Holdings, Inc.: Lantheus Announces Sale of SPECT Business to SHINE Technologies | Enables Lantheus to focus on innovative radiopharmaceuticals, while maximizing the value of its SPECT business SHINE will acquire products TechneLite®, NEUROLITE®, Xenon Xe-133 Gas, and Cardiolite®... ► Artikel lesen | |
| AMEDISYS | 82,00 | -0,61 % | Proposed Medicare payment cut for home health could scuttle UnitedHealth/Amedisys deal | ||
| ENVISTA | 16,500 | 0,00 % | Hitachi Digital Services Announces Five-Year Strategic IT Partnership with Envista | DALLAS, May 15, 2025 /PRNewswire/ -- Hitachi Digital Services, the digital consultancy and technology services subsidiary of Hitachi, Ltd. (TSE: 6501), today... ► Artikel lesen | |
| CAREDX | 15,570 | -3,62 % | CareDx, Inc.: CareDx gibt Studie bekannt, die zeigt, dass AlloSeq cfDNA bei der Erkennung von Abstoßungsreaktionen bei Organtransplantationspatienten äußerst genau ist | AlloSeq cfDNA entspricht der Leistung des bewährten AlloSure-Tests CareDx bringt mit AlloSeq cfDNA ein innovatives nicht-invasives Transplantationsmonitoring für Patienten auf internationaler... ► Artikel lesen | |
| SYNEOS HEALTH | - | - | Research Solutions, Inc.: Research Solutions Reports Fiscal Third Quarter 2025 Results | Reports 23 Percent Increase in ARR to $20.4 Million and 43 Net New Platform Deployments, Positive Net Income and Record Adjusted EBITDA and Cashflow
HENDERSON... ► Artikel lesen | |
| GT BIOPHARMA | 2,050 | -5,96 % | GT Biopharma, Inc.: GT Biopharma Advances GTB-3650 Phase 1 Trial to Cohort 2 Following Successful Initial Human Dosing and Evidence of Early Immune Activation Signals | Following the formal safety review of Cohort 1, no safety or tolerability issues were observed, allowing the company to move forward with Cohort 2. The company plans on releasing more detailed results... ► Artikel lesen | |
| CARMAT | 0,630 | -3,82 % | XFRA CXT: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| CHEMOMETEC | 73,20 | -0,54 % | Chemometec A/S: Preliminary revenue figures for the 2024/25 financial year | ANNOUNCEMENT NO. 290 1 July 2025 Preliminary revenue figures for the 2024/25 financial year Based on the preliminary financial figures, ChemoMetec now expects revenue of around DKK 496 million... ► Artikel lesen | |
| ARRAIL GROUP | 0,216 | 0,00 % | ARRAIL GROUP (06639): CONNECTED TRANSACTION IN RELATION TO AMENDMENT TO THE LOAN AGREEMENT AND PLEDGE OF SHARES BY THE CONTROLLING SHAREHOLDER | ||
| PROMIMIC | 1,815 | +23,47 % | Curiteva & Promimic - Bonded by Innovation | HUNTSVILLE, ALABAMA / ACCESS Newswire / May 6, 2025 / Curiteva, a leader in 3D-printed Trabecular PEEK implant technology, is pleased to announce an expanded partnership with Promimic, pioneers in nanotechnology... ► Artikel lesen | |
| DEVYSER DIAGNOSTICS | 11,620 | +0,52 % | Devyser Diagnostics AB: Devyser launches Genomic Blood Typing assay: All blood groups, one simple test | Devyser today announced the global launch of Devyser Genomic Blood Typing, a next-generation sequencing (NGS)-based solution that redefines molecular blood group research. Developed exclusively, this... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 46,910 | +0,67 % | Siemens Healthineers: Europa und USA als Wachstumstreiber | Siemens Healthineers wird am 30. Juli Zahlen zum dritten Quartal publizieren. Die Analysten der Deutschen Bank geben eine Vorschau auf ihre Erwartungen. Demnach soll der Umsatz organisch um 6 Prozent... ► Artikel lesen | |
| FRESENIUS | 41,990 | -1,04 % | Aktie von Fresenius SE & Co. KGaA: Kurs heute nahezu konstant (42,73 €) | Die Wertschätzung für den Anteilsschein von Fresenius SE & Co. KGaA hat sich am Aktienmarkt heute kaum geändert. Das Wertpapier notiert zur Stunde bei 42,73 Euro. Kaum auffällig ist derzeit an der Börse... ► Artikel lesen |
Das Unternehmen POLAREAN IMAGING PLC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,019 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu POLAREAN IMAGING PLC finden Sie auf Wallstreet Online.